John Maroney joined ForSight VISION 5 as President and CEO in July 2013, a clinical development stage company working on sustained release of medications to the anterior eye. Prior to VISION 5, he served as a Managing Member of Delphi Ventures, a healthcare focused venture capital firm. Before Delphi, John was president, CEO, and chairman of EndoTex Interventional Systems, Inc. a development stage, venture backed, start-up company focused on commercialization of carotid artery stents, acquired by Boston Scientific in 2007. From 1988 to 1997, he held a variety of senior management positions at Cardiovascular Imaging Systems and Boston Scientific, and was a key member of the senior management team during the CVIS IPO and eventual acquisition by Boston Scientific. John serves on the Advisory Boards for the College of Engineering and the Department of Biomedical Engineering at U.C. Davis, where he earned his B.S. in Mechanical Engineering.
John’s thrice great-grandmother, Catherine Maroney, immigrated to New York during the Famine from Limerick, along with his great-great-grandfather, Martin. He and his wife Sarah Bryan live in Woodside, California.